Texas cancer center guilty of selling foreign-made Avastin

A cancer center in Texas has pleaded guilty to using foreign-made versions of Roche's ($RHHBY) cancer drug Avastin on patients. According to the the FDA, Dr. Mohamad Ayman Ghraowi agreed to plead guilty on behalf of Corpus Christi-based South Texas Comprehensive Cancer Centers for buying $900,000 worth of "misbranded drugs," between Feb. 22, 2010, and Jan. 17, 2012. The company was given 5 years' probation and ordered to pay $900,000. The FDA said the drugs were tracked from a company in the U.K. to an unauthorized wholesaler in the U.S. The feds, since discovering the illegal drugs in the U.S. in 2012, have gotten convictions of a number of players from smugglers and wholesalers to some doctors and clinics that admitted buying the drugs at discounts, knowing they were unapproved. Release | More

Suggested Articles

McCallum was hit with a warning letter from the FDA for testing issues with its products and failing to keep appropriate records.

The FDA made public a voluntary recall of sterile injectables made by Coastal Meds of Mississippi, after visible particles were found in some vials.

The FDA hit New Jersey-based CMO Tris Pharma with a warning letter, citing significant violations.